İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

FATMA KEKLİK KARADAĞ

DOKTOR ÖĞRETİM ÜYESİ

EGE ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Hematoloji (İç Hastalıkları)

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 42
  • Proje 0
  • Kitap 9
  • Bildiri 52
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 9 Q2 7 Q3 9 Q4 5
WoS (JCR) Q1 7 Q2 6 Q3 9 Q4 9
TR Index 14 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 2
Ort. yüzdelik 55.8%
Üst %1 payı 0.0%
Üst %10 payı 6.9%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 42 yayın

Makale listesi

  1. 2025 Systemic Mastocytosis: Current Status and Challenges in 2024 Blood Advances DOI 10.1182/bloodadvances.2024012612 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.0%
  2. 2025 Effect of Iron Accumulation on Bone Mineral Density in Patients Diagnosed With Transfusion‐Dependent Thalassemia International Journal of Clinical Practice DOI 10.1155/ijcp/5411059 YÖKSİS SJR Q2 JCR Q2 OpenAlex 66.0%
  3. 2025 Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Groups large B‐cell lymphoma cohort British Journal of Haematology DOI 10.1111/bjh.20111 YÖKSİS SJR Q1 JCR Q2 OpenAlex 69.8%
  4. 2025 A Large Room for Improvement Concerning the Management of Relapsed Refractory Large B-cell Lymphoma in Türkiye: Real-World Outcomes in the Setting Without Access to T-Cell Redirecting Therapies Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2025.2025.0352 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 75.0%
  5. 2025 A retrospective evaluation of chronic myeloid leukemia patients treated with imatinib Ege Tıp Dergisi DOI https://dergipark.org.tr/en/download/article-file/4592464 YÖKSİS TR Index
  6. 2024 Prognostic impact of next-generation sequencing on myelodysplastic syndrome: A single-center experience Medicine DOI 10.1097/MD.0000000000039909 YÖKSİS SJR Q3 JCR Q2 OpenAlex 83.0%
  7. 2024 Systemic Mastocytosis in Adults: Long-Term Follow up and Real-Life Experience International Journal of Hematology and Oncology DOI 10.4999/uhod.247476 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 10.5%
  8. 2024 The assessment of health-related quality of life in patients with polycythemia vera Medicine DOI 10.1097/MD.0000000000038814 YÖKSİS SJR Q3 JCR Q2 OpenAlex 56.3%
  9. 2024 Does immunohistochemical staining predict mobilization success in multiple myeloma patients? TRANSFUSION AND APHERESIS SCIENCE DOI 10.1016/j.transci.2024.104004 YÖKSİS SJR Q3 JCR Q4 OpenAlex 20.9%
  10. 2024 A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients Leukemia & Lymphoma DOI 10.1080/10428194.2024.2395458 YÖKSİS SJR Q2 JCR Q3 OpenAlex 84.7%
  11. 2024 JAKCalc: A machine-learning approach to rationalized JAK2 testing in patients with elevated hemoglobin levels Medicine DOI 10.1097/MD.0000000000037751 YÖKSİS SJR Q3 JCR Q2 OpenAlex 75.9%
  12. 2024 Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience Leukemia Research DOI 10.1016/j.leukres.2024.107495 YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.8%
  13. 2024 Incidental Diagnosis of Cyclic Thrombocytopenia: An Asymptomatic Case Cureus DOI 10.7759/cureus.66310 YÖKSİS JCR Q2 OpenAlex 16.2%
  14. 2024 Evaluation of Socio-demographic Factors and Comorbidities in Adult Hemophilia Patients Journal of Basic and Clinical Health Sciences DOI 10.30621/jbachs.1416117 YÖKSİS TR Index JCR Q4 OpenAlex 9.8%
  15. 2024 A novel challenge in elderly people with hemophilia: Cancer Ege Tıp Dergisi YÖKSİS TR Index
  16. 2024 Nodüler Lenfosit Predominant Hodgkin Lenfoma Tedavisinde Rituksimab Temelli Rejimlerin Sağkalıma Katkısı LLM Dergi DOI 10.5578/llm.202402142 YÖKSİS TR Index OpenAlex 23.3%
  17. 2023 Clinical Outcomes of CNS Lymphoma Treated with Ibrutinib-Based Therapy: A Real-Life Multicenter Experience on Off-Label Use of Ibrutinib UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi DOI 10.4999/uhod.237297 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 54.1%
  18. 2023 Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2023.2023.0295 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 59.5%
  19. 2023 Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2023.2023.0029 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 71.8%
  20. 2023 Adherence to hemophilia patients with prophylaxis: Veritas-Pro and psychometric properties adapted to Turkish PLOS ONE DOI 10.1371/journal.pone.0288625 YÖKSİS SJR Q1 JCR Q1 OpenAlex 46.1%

Akademisyenlere dön